| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 07/14/2004 | CN1511830A Compound used as antiphlogistic |
| 07/13/2004 | US6762309 Antileukemia and antitumor agents |
| 07/13/2004 | US6762200 Phospholipase inhibitors |
| 07/13/2004 | US6762197 Fungicides |
| 07/13/2004 | US6762194 Quinolinone derivatives |
| 07/13/2004 | US6762190 Vitronectin receptor antagonists; suppressing osteoclast bone resorption; preventing angiogenesis or vascular smooth muscle proliferation |
| 07/13/2004 | US6761981 High efficiency and long service life; marcrocyclic rings comprising tertiary amines contained in a hole transport layer and/or luminescent layer of an electroluminescent device such as flat screen display |
| 07/13/2004 | CA2313106C Tetrazolylalkyl indole compounds as anti-inflammatory and analgesic agents |
| 07/13/2004 | CA2244771C Substituted 3-aryl-3-carboxyalkyl glutaramides, method for preparing same, and use thereof |
| 07/08/2004 | WO2004056815A1 PYRAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 07/08/2004 | WO2004056813A1 Benzodiazepine derivative |
| 07/08/2004 | WO2004056807A1 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 07/08/2004 | WO2004056800A1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056799A2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056786A2 Pyrimidine derivates for the treatment of abnormal cell growth |
| 07/08/2004 | WO2004056784A1 Novel carboxamides, the production and use thereof as medicaments |
| 07/08/2004 | WO2004056782A1 Pyrazole compounds |
| 07/08/2004 | WO2004056780A2 Tetrahydroquinoline derivatives |
| 07/08/2004 | WO2004056779A2 Tetrahydroquinoline derivatives and their use as fsh receptor modulators |
| 07/08/2004 | WO2004056775A1 Microsomal triglyceride transfer protein inhibitors |
| 07/08/2004 | WO2004056772A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as tachykinin antagonists |
| 07/08/2004 | WO2004056769A2 Synthesis of amines and intermediates for the synthesis thereof |
| 07/08/2004 | WO2004056755A2 Compounds for the inhibition of non-proteolytic enzymes |
| 07/08/2004 | WO2004056727A2 Process of making chalcone derivatives |
| 07/08/2004 | WO2004056369A1 Benzo ‘ d!azepine derivatives for the treatment of neurological disorders |
| 07/08/2004 | WO2004056365A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone |
| 07/08/2004 | WO2004056364A1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004050018A3 Dicationic 2,5-diarylfuran aza-analogs as anti-protozoan agents |
| 07/08/2004 | WO2004041755A3 Quinazolinone compounds as calcilytics |
| 07/08/2004 | WO2004026230A3 Method of preparing amino acid taxane derivatives and polymer conjugates containing the same |
| 07/08/2004 | WO2003106628A3 Benzodiazepine inhibitors of mitochondial f¿1<f¿0? atp hydrolase and methods of inhibiting f¿1?f¿0? atp hydrolase |
| 07/08/2004 | WO2003103663A3 Substituted pyrrolines as kinase inhibitors |
| 07/08/2004 | WO2003103599A3 Caspase-1 inhibitors and methods for their use |
| 07/08/2004 | WO2003097598A8 Compound exhibiting pgd 2 receptor antagonism |
| 07/08/2004 | US20040133011 Useful for therapy of noninsulin-dependent diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome |
| 07/08/2004 | US20040133008 Amide compounds |
| 07/08/2004 | US20040132960 Polymers having pendant nonlinear optical chromophores and electro-optic devices therefrom |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132807 Aurones as telomerase inhibitors |
| 07/08/2004 | US20040132788 thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives; treating neurodegenerative disorders or pain. |
| 07/08/2004 | US20040132782 Aspartyl protease inhibitors |
| 07/08/2004 | US20040132781 Pyrazole compounds useful as protein kinase inhibitors |
| 07/08/2004 | US20040132779 benzoyl- or pyridinoyl-amimo phenyl- or pyridinylmethylaminocarbonyl compounds, e.g., 4-[(2-acetylamino-2-phenyl-acetylamino)-methyl]-2-methylphenyl-4'-trifluoromethylbiphenyl-2-carboxamide; antiobesity and antiatherosclerosis agents |
| 07/08/2004 | US20040132775 cyclodehydrating an oxy-substituted phenylthiomethyl phenyl ketone in the presence of an acid activated clay or acid activated zeolite catalyst and in the presence of a suitable solvent, such as toluene |
| 07/08/2004 | US20040132772 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis |
| 07/08/2004 | US20040132752 cyclic ureas and triazolones; treatment or prevention of excessive weight or obesity, and for treatment of Type II diabetes, arteriosclerosis, high blood pressure, depression, anxiety, anxiety neuroses, and schizophrenia. |
| 07/08/2004 | US20040132744 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications. |
| 07/08/2004 | US20040132741 N-sulfonylindoles and N-sulfonylindazoles; treating motor disorders, anxiety disorders or cognitive disorders, such as schizophrenia, depression, Alzheimer's disease or Parkinson's disease |
| 07/08/2004 | US20040132738 e.g., 3-[(5-benzyloxypyridin-2-yl)methylidene]-6-phenylmethylidene piperazine-2,5-dione; treating an angiogenesis-related disease. |
| 07/08/2004 | US20040132736 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/08/2004 | US20040132733 Novel quinoxalinone derivatives as bradykinin B1 antagonists |
| 07/08/2004 | US20040132730 Inhibitors of TGFbeta |
| 07/08/2004 | US20040132727 Quinoline and quinazoline derivatives and drugs containing the same |
| 07/08/2004 | US20040132720 Antidepressants |
| 07/08/2004 | US20040132718 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
| 07/08/2004 | US20040132717 2-Oxo-piperidinyl-and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders |
| 07/08/2004 | US20040132693 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha converting enzyme (TACE) |
| 07/08/2004 | CA2511321A1 Pyrazole-derivatives as factor xa inhibitors |
| 07/08/2004 | CA2510848A1 Pyrimidine derivates for the treatment of abnormal cell growth |
| 07/08/2004 | CA2510846A1 New carboxylic acid amides,the preparation thereof and their use as pharmaceutical compositions |
| 07/08/2004 | CA2510815A1 Microsomal triglyceride transfer protein inhibitors |
| 07/08/2004 | CA2509403A1 Pyrazole compounds |
| 07/08/2004 | CA2508657A1 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | CA2508290A1 Synthesis of amines and intermediates for the synthesis thereof |
| 07/07/2004 | EP1435356A1 Quinoline derivatives as CRTH2 antagonists |
| 07/07/2004 | EP1434775A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 07/07/2004 | EP1434765A1 Substituted piperidines with selective binding to histamine h3-receptor |
| 07/07/2004 | EP1434763A2 Beta-lactamyl vasopressin v1a antagonists |
| 07/07/2004 | EP1434581A1 3- hydroxy-(-4-trifluoromethylphenyl)-methyl-7-spirocyclobutyl-5,6,7,8-tetrahydroquinolin-5-ol derivatives and the use of the same as cholesterol ester transfer protein (cetp) inhibitors |
| 07/07/2004 | EP1434580A2 Allylamides useful in the treatment of alzheimer's disease |
| 07/07/2004 | EP1434579A1 Imidazole derivatives as antiinflammatory agents |
| 07/07/2004 | EP1434577A1 Pyrrolidinone derivatives |
| 07/07/2004 | EP1434485A1 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 07/07/2004 | EP1401431A4 Human growth hormone antagonists |
| 07/07/2004 | EP0946552B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 07/07/2004 | CN1511151A 3-quinoline-2-(1H)-ylideneindolin-2-one derivatives |
| 07/07/2004 | CN1511143A Herbicidal substituted benzoylpyrazoles |
| 07/07/2004 | CN1511140A Oxime ether compound and agricultural or horticultural bactericide |
| 07/07/2004 | CN1156470C New Substituted pyridyl keto enols |
| 07/07/2004 | CN1156452C Compound as anti-inflammatory agent |
| 07/07/2004 | CN1156446C Indenoindolone compounds, their preparation and medicinal compositions containing them |
| 07/06/2004 | US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/06/2004 | US6759548 Dialkyl-halogenophenyl-substituted ketoenols |
| 07/06/2004 | US6759428 Indole nitriles |
| 07/06/2004 | US6759415 Affinity with subtypes of somatostatin receptors |
| 07/06/2004 | US6759414 Aromatic amides |
| 07/06/2004 | US6759411 Heterocyclic piperidines as modulators of chemokine receptor activity |
| 07/06/2004 | US6759406 Quaternary ammonium compounds |
| 07/01/2004 | WO2004055015A1 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 07/01/2004 | WO2004055010A2 Cyclopropyl compounds as ccr5 antagonists |
| 07/01/2004 | WO2004055009A1 Novel compounds having selective inhibiting efect at gsk3 |
| 07/01/2004 | WO2004055007A1 3-substituted-4-pyrimidone derivatives |
| 07/01/2004 | WO2004055004A1 Carboxylic acid, phosphate or phosphonate substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 07/01/2004 | WO2004055003A1 2-substituted quinazolin-4-ylamine analogues as capsaicin receptor modulators |
| 07/01/2004 | WO2004054999A1 Enantiomers of thiophene hydroxamic acid derivatives and their use as hdac inhibitors |
| 07/01/2004 | WO2004054987A1 Cathepsin cysteine protease inhibitors and their use |
| 07/01/2004 | WO2004054979A1 Jnk inhibitors |
| 07/01/2004 | WO2004054977A1 Nicotinamide-based kinase inhibitors |
| 07/01/2004 | WO2004054971A1 Method for production of the r,r (or s,s) configuration of glycopyrronium stereoisomers |
| 07/01/2004 | WO2004054624A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands |